Assignee
NUVAMID SA
CH·3 granted patents·19 pending applications·2 citations·filing 2020–2025
Top patents by PatentIndex Score
22 records- 0181US11730752B2Use of NMN for the prevention and/or treatment of joint pain induced by physical activity, and corresponding compositionsNUVAMID SA·Filed 2021·Granted Aug 22, 2023·2 cites·15 claims
- 0265US2024417421A1NMN And Derivatives For Its Use In The Treatment Of Depression And/Or Anxiety In Patients Having A Form Of ParkinsonismNUVAMID SA·Filed 2024·Application pending·0 cites
- 0365US2026091051A1Use of nmn for the prevention and/or treatment of pain, and corresponding compositionsNUVAMID SA·Filed 2025·Application pending·0 cites
- 0458US12403153B2Nicotinamide mononucleotide derivatives and use thereof in the treatment and prevention of a red blood cell disorderNUVAMID SA·Filed 2021·Granted Sep 2, 2025·0 cites·9 claims
- 0558US2024116971A1Nmn and derivatives for its use in the treatment of depression and/or anxiety in patients having a form of parkinsonismNUVAMID SA·Filed 2022·Application pending·0 cites
- 0657US12011454B2Nicotinamide mononucleotide derivatives and use thereof in the treatment and prevention of a red blood cell disorderNUVAMID SA·Filed 2023·Granted Jun 18, 2024·0 cites·16 claims
- 0750US2023210746A1Anti-aging cosmetic compositions comprising nmnNUVAMID SA·Filed 2021·Application pending·0 cites
- 0847US2024382511A1Nicotinamide mononucleotide derivatives and use thereof for the treatment of heart failure with preserved ejection fractionNUVAMID SA·Filed 2022·Application pending·0 cites
- 0947US2022323477A1Use of nmn for the prevention and/or treatment of pain, and corresponding compositionsNUVAMID SA·Filed 2020·Application pending·0 cites
- 1047US2024335466A1Nicotinamide mononucleotide derivatives for use in the treatment of sapho syndromeNUVAMID SA·Filed 2022·Application pending·0 cites
- 1146US2023321131A1Nicotinamide mononucleotide derivatives and use thereof in the treatment and prevention of an antineoplastic-induced toxicityNUVAMID SA·Filed 2021·Application pending·0 cites
- 1245US2023136569A1Use of nmn to reduce immunodepression and immunosenescenceNUVAMID SA·Filed 2021·Application pending·0 cites
- 1344US2023097603A1Nicotinamide mononucleotide derivatives for the treatment of arrhythmiaNUVAMID SA·Filed 2021·Application pending·0 cites
- 1444US2023172959A1Use of nmn for the prevention and/or treatment of a back pain and corresponding compositionsNUVAMID SA·Filed 2021·Application pending·0 cites
- 1543US2023210881A1Nicotinamide mononucleotide derivatives for the treatment of bacterial infectionsNUVAMID SA·Filed 2021·Application pending·0 cites
- 1643US2023150984A1Nicotinamide mononucleotide and nicotinamide riboside derivatives and use thereof in the treatment of viral infections and respiratory complications, in particular caused by influenzavirus or coronavirusNUVAMID SA·Filed 2021·Application pending·0 cites
- 1742US2023096443A1Novel nicotinamide di-nucleotide derivatives and use thereofNUVAMID SA·Filed 2020·Application pending·0 cites
- 1842US2023149435A1Use of nmn for the prevention and/or treatment of muscle, ligament or tendon pain induced by physical activity and corresponding compositionsNUVAMID SA·Filed 2021·Application pending·0 cites
- 1942US2024122957A1Use of nicotinamide mononucleotide (nmn) for the prevention and/or treatment of rheumatoid arthritis, and corresponding compositionsNUVAMID SA·Filed 2020·Application pending·0 cites
- 2041US2023002368A1Use of compounds for the prevention and/or treatment of ankylosing spondylitis, and corresponding compositionsNUVAMID SA·Filed 2020·Application pending·0 cites
- 2140US2021353656A1Combination of nicotinamide mononucleotide derivatives and histamine h2 receptor antagonists for viral infectionsNUVAMID SA·Filed 2020·Application pending·0 cites
- 2235US2021332033A1Nicotinamide mononucleotide derivatives and use thereof in the treatment of viral infectionsNUVAMID SA·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NUVAMID SA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →